Why Organogenesis Holdings Stock Is Soaring Today

1 min read

Shares of regenerative medicine company Organogenesis Holdings (NASDAQ: ORGO) are skyrocketing on Thursday on high trading volume following two pieces of good news the drugmaker announced in the past 24 hours. Organogenesis Holdings’ stock is up by 37.9% as of 12:34 p.m. EST after rising by as much as 43.2% today. 

On Wednesday evening Organogenesis Holdings announced preliminary results for its fourth quarter of fiscal 2020. The company said it expects its net revenue to come in between $104.6 million and $106 million, which would represent a 40%-to-42% year-over-year increase. On average, analysts predicted that the drugmaker’s revenue for the fourth quarter would be $80.84 million. For the 12-month period that ended on Dec. 31, Organogenesis Holdings thinks it will record net revenue between $336.1 million and $337.5 million, an increase of roughly 29% compared to fiscal 2019.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Why Aldeyra Therapeutics Stock Is Jumping Today

Next Story

Wells Fargo to Sell its Canadian Equipment Finance Business

Latest from Blog